Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:13 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 100 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Fibrillation, Ventricular Clear all

Conditions: Atrial Fibrillation
Interventions: Placebo, Etripamil; Drug
Lead sponsor: Milestone Pharmaceuticals Inc.; Other
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 9
States / cities: Vista, California • West Hills, California • Littleton, Colorado + 6 more

Conditions: Atrial Fibrillation With Rapid Ventricular Response, Hypotension Drug-Induced
Interventions: Calcium pre-treatment, Placebo; Drug · Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Oak Lawn, Illinois

Conditions: Hypertrophic Cardiomyopathy, Nonsustained Ventricular Tachycardia, Ventricular Tachycardia, Atrial Fibrillation, Arrhythmia
Interventions: Zio XT; Device
Lead sponsor: iRhythm Technologies, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Ventricular Tachyarrhythmias
Interventions: Not listed
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 90 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: San Diego, California

Conditions: Ischemic Cardiomyopathy, Nonischemic Cardiomyopathy
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2030
U.S. locations: 2
States / cities: Newark, Delaware • Baltimore, Maryland

Conditions: Atrial Fibrillation, Atrial Flutter, Supraventricular Tachycardia, Syncope, Ventricular Tachycardia
Interventions: Early mobilization; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Portland, Oregon

Conditions: Ventricular Tachycardia, Ventricular Fibrillation, Atrial Fibrillation, Supraventricular Tachycardia
Interventions: Dual Chamber ICD, Single Chamber ICD; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Atrial Fibrillation, Tachycardia, Bradycardia, Premature Supraventricular Beat, Premature Ventricular Contraction
Interventions: Cardiologs Platform; Device
Lead sponsor: Cardiologs Technologies; Industry
Eligibility: 18 Years and older
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 3
States / cities: Hackensack, New Jersey • Ridgewood, New Jersey • New York, New York

Conditions: Cardiac Arrest Due to Underlying Cardiac Condition, Ventricular Fibrillation, Cardiopulmonary Arrest With Successful Resuscitation
Interventions: Initial CCL admission, Initial ICU admission; Procedure · Diagnostic Test
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 21
States / cities: Atlanta, Georgia • Indianapolis, Indiana • Ann Arbor, Michigan + 14 more

Conditions: Myocardiopathies, Ischemia, Myocardial, Arrythmia, Death, Sudden, Cardiac
Interventions: Not listed
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Ventricular Tachycardia, Ventricular Fibrillation, Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 142 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 3
States / cities: Chicago, Illinois • Charleston, South Carolina • Richmond, Virginia

Conditions: Atrial Fibrillation, Aortic Valve Stenosis
Interventions: WATCHMAN, TAVR; Device
Lead sponsor: samir kapadia; Other
Eligibility: 18 Years and older
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 32
States / cities: Phoenix, Arizona • Burlingame, California • Santa Barbara, California + 27 more

Conditions: Ventricular Arrhythmias
Interventions: spironolactone, placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Heart Failure, Heart Failure With Reduced Ejection Fraction, Implantable Defibrillator User, CCM Therapy, Non-ischemic Cardiomyopathy, Ischemic Cardiomyopathy, Sudden Cardiac Arrest, Arrhythmias, Cardiac, Ventricular Tachycardia, Ventricular Fibrillation
Interventions: OPTIMIZER® Integra CCM-D System (Treatment Arm); Device
Lead sponsor: Impulse Dynamics; Industry
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 59
States / cities: Glendale, Arizona • Mesa, Arizona • Phoenix, Arizona + 40 more

Conditions: Arrhythmia, Tachycardia, Atrial Fibrillation, Ventricular Fibrillation
Interventions: Remote Management, In-Office Care; Other
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 2,009 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 127
States / cities: Mobile, Alabama • Mesa, Arizona • Scottsdale, Arizona + 124 more

Conditions: Ventricular Tachycardia
Interventions: Bipolar Ablation; Device
Lead sponsor: Srinivas Dukkipati; Other
Eligibility: 18 Years and older
Enrollment: 145 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 6
States / cities: Maywood, Illinois • Boston, Massachusetts • New York, New York + 2 more

Conditions: Arrhythmias, Cardiac
Interventions: Not listed
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 2,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2035
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Congestive Heart Failure, Left Ventricular Failure, Atrial Fibrillation
Interventions: Catheter Ablation, FDA approved anti arrhythmic drug; Device · Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 6
States / cities: Hartford, Connecticut • Akron, Ohio • Cleveland, Ohio + 3 more

Conditions: Heart Failure, Defibrillators, Implantable, Monitoring, Physiologic, Cardiac Resynchronization Therapy, Cardiovascular Disease, Heart Disease
Interventions: HeartLogic Sensors; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 2,184 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 56
States / cities: Birmingham, Alabama • Jonesboro, Arkansas • Little Rock, Arkansas + 48 more

Conditions: Myocardial Infarction, Ventricular Dysfunction, Sudden Death, Ventricular Tachycardia, Ventricular Fibrillation
Interventions: wearable defibrillator; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 2,348 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2019
U.S. locations: 57
States / cities: Anchorage, Alaska • Fresno, California • Salinas, California + 47 more

Conditions: Sudden Cardiac Arrest
Interventions: Machine learning-guided cardiac arrest prediction device; Device
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Ventricular Fibrillation, Cardiac Arrest
Interventions: Automated external defibrillator (Philips FR2+ AED), SmartCPR, Delayed defibrillation; Device · Other
Lead sponsor: New York City Fire Department; Government
Eligibility: Not listed
Enrollment: 900 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: New York, New York

Conditions: Cardiac Arrest
Interventions: Defibrillation (biphasic versus monophasic shock); Device
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Tachycardia, Ventricular, Ventricular Fibrillation
Interventions: Methods for monitoring patients with ICD's; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 151 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Diltiazem in the Treatment of Atrial Fibrillation or Atrial Flutter With Rapid Ventricular Rate

Extended ECG Monitoring in HCM Patients

Ablation of Ventricular Fibrillation by Accurate Targeting of Arrhythmogenic Regions (AVATAR)

Left Ventricular Structural Predictors of Sudden Cardiac Death

The Z Stitch Early Bed Rest Assessment Study

The Use of Dual Chamber ICD With Special Programmed Features to Lower the Risk of Inappropriate Shock

Electrocardiographic Diagnostic Performance of the Apple Watch Augmented With an Artificial Intelligence Algorithm

ACCESS to the Cardiac Cath Lab in Patients Without STEMI Resuscitated From Out-of-hospital VT/VF Cardiac Arrest

Extracellular Matrix Marker of Arrhythmia Risk (EMMA)

First Arrhythmia Collection of Transvenous and Simultaneous Subcutaneous Implantable Defibrillator Data

WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement

Antiarrhythmic Effects of Spironolactone in Patients With ICDs

Assessment of Combined CCM and ICD Device in HFrEF

CONNECT Study - Clinical Evaluation Of Remote NotificatioN to rEduCe Time to Clinical Decision

Bipolar Ventricular Tachycardia (VT) Study

Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic

Catheter Ablation vs. Medical Therapy in Congested Hearts With AF

Precision Event Monitoring for Patients With Heart Failure Using HeartLogic

Vest Prevention of Early Sudden Death Trial and VEST Registry

AI-guided Prediction and Treatment of Cardiac Arrest

SmartCPR Trial: An Analysis of a Waveform-Based Automated External Defibrillation (AED) Algorithm on Survival From Out-of-Hospital Ventricular Fibrillation

Transthoracic Incremental Monophasic Versus Biphasic by Emergency Responders (TIMBER)

A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic